MTOR and systemic lupus erythematosus: Treatment with N-acetylcysteine (NAC) can alleviate this phenomenon by reducing mTOR activity, thus increasing T cell mitochondrial membrane potential and cell apoptosis, as well as inducing the expression of nTregs in SLE patients (106).